Biomolecules & Therapeutics

The Korean Society of Applied Pharmacology (한국응용약물학회)
권호 표지
DOI QR코드

DOI QR Code

Suppression of Prostaglandin E2-Mediated Cell Proliferation and Signal Transduction by Resveratrol in Human Colon Cancer Cells

  • Received : 2010.09.06
  • Accepted : 2010.09.15
  • Published : 2010.10.31
Download PDF
⟨ Previous Next ⟩

Abstract

Although the overproduction of prostaglandin $E_2$ ($PGE_2$) in intestinal epithelial cells has been considered to be highly correlated with the colorectal carcinogenesis, the precise mechanism of action remains poorly elucidated. Accumulating evidence suggests that the PGE receptor (EP)-mediated signal transduction pathway might play an important role in this process. In the present study, we investigated the mechanism of action underlying $PGE_2$-mediated cell proliferation and the effect of resveratrol on the proliferation of human colon cancer cells in terms of the modulating $PGE_2$-mediated signaling pathway. $PGE_2$ stimulated the proliferation of several human colon cancer cells and activated growth-stimulatory signal transduction, including Akt and ERK. $PGE_2$ also increased the phosphorylation of GSK-$3{\beta}$, the translocation of ${\beta}$-catenin into the nucleus, and the expressions of c-myc and cyclin D1. Resveratrol, a cancer chemopreventive phytochemical, however, inhibited $PGE_2$-induced growth stimulation and also suppressed $PGE_2$-mediated signal transduction, as well as ${\beta}$-catenin/T cell factor-mediated transcription in human colon cancer cells. These findings present an additional mechanism through which resveratrol affects the regulation of human colon cancer cell growth.

Keywords

References

  1. Bhat, K. P. L. and Pezzuto, J. M. (2002). Cancer chemopreventive activity of resveratrol. Ann. N.Y. Acad. Sci. 957, 210-229. https://doi.org/10.1111/j.1749-6632.2002.tb02918.x
  2. Buchanan, F. G., Wang, D., Bargiacchi, F. and DuBois, R. N. (2003). Prostaglandin $E_2$ regulates cell migration via the intracellular activation of the epidermal growth factor receptor. J. Biol. Chem. 278, 35451-35457. https://doi.org/10.1074/jbc.M302474200
  3. Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M. and Gutkind, J. S. (2005). Prostaglandin $E_2$ promotes colon cancer cell growth through a Gs-axin-$\beta$-catenin signaling axis. Science 310, 1504-1510. https://doi.org/10.1126/science.1116221
  4. DuBois, R. N., Radhika, A., Reddy, B. S. and Entingh, A. J. (1996). Increased cyclooxygenase-2 levels in carcinogeninduced rat colonic tumors. Gastroenterology 110, 1259- 1262. https://doi.org/10.1053/gast.1996.v110.pm8613017
  5. Eberhart, G. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S. and DuBois, R. N. (1994). Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenoma and adnocarcinomas. Gastroenterology 107, 1183-1188. https://doi.org/10.1016/0016-5085(94)90246-1
  6. Fujino, H., West, K. A. and Regan, J. W. (2002). Phosphorylation of glycogen synthase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2. J. Biol. Chem. 277, 2614- 2619. https://doi.org/10.1074/jbc.M109440200
  7. Giardiello, F. M., Yang, V. W., Hylind, L. M., Krush, A. J., Petersen, G. M., Trimbath, J. D., Piantadosi, S., Garrett, E., Geiman, D. E., Hubbard, W., Offerhaus, G. J. and Hamilton, S. R. (2002). Primary chemoprevention of familial adenomatous polyposis with sulindac. New Engl. J. Med. 346, 1054-1059. https://doi.org/10.1056/NEJMoa012015
  8. Hansen-Petrik, M. B., McEntee, M. F., Jull, B., Shi, H., Zemel, M. B. and Whelan J. (2002). Prostaglandin $E_2$ protects intestinal tumors from nonsteroidal anti-inflammatory druginduced regression in Apc(Min/＋) mice. Cancer Res. 62, 403-408.
  9. Hsieh, T. C. and Wu, J. M. (1999). Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines. Exp. Cell Res. 249, 109-115. https://doi.org/10.1006/excr.1999.4471
  10. Hull, M. A., Ko, S. C. W. and Hawcroft, G. (2004). Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol. Cancer Ther. 3, 1031-1039. https://doi.org/10.4161/cbt.3.10.1227
  11. Joe, A. K., Liu, H., Suzui, M., Vural, M. E., Xiao, D. and Weinstein, I. B. (2002). Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 8, 893-903.
  12. Kawamori, T., Uchiya, N., Sugimura, T. and Wakabayashi, K. (2003). Enhancement of colon carcinogenesis by prostaglandin $E_2$ administration. Carcinogenesis 24, 985-990. https://doi.org/10.1093/carcin/bgg033
  13. Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y. and Lin, J. K. (2003). Resveratrol-induced G2 arrest through the inhibition of CDK7 and $p34^{CDC2}$ kinases in colon carcinoma HT29 cells. Biochem. Pharmacol. 65, 1053-1060. https://doi.org/10.1016/S0006-2952(03)00011-X
  14. Mutoh, M., Takahashi, M., Fukuda, K., Matsushima-Hibiya, Y., Mutoh, H., Sugimura, T. and Wakabayashi, K. (2000). Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis 21, 959-963. https://doi.org/10.1093/carcin/21.5.959
  15. Nam, K. A., Heo, Y. H. and Lee, S. K. (2003). Cytotoxic activity and G2/M cell cycle arrest mediated by antofine, a phenanthroindolizidine alkaloid isolated from Cynanchum paniculatum. Planta Med. 69, 21-25. https://doi.org/10.1055/s-2003-37021
  16. Pai, R., Nakamura, T., Moon, W. S. and Tarnawski, A. S. (2003). Prostaglandins promote colon cancer cell invasion: signaling by cross-talk between two distinct growth factor receptors. FASEB J. 17, 1640-1647. https://doi.org/10.1096/fj.02-1011com
  17. Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D. and Tarnawski, A. S. (2002). Prostaglandin $E_2$ transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8, 289- 293. https://doi.org/10.1038/nm0302-289
  18. Pugh, S. and Thomas, G. A. (1994). Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin $_E2$. Gut 35, 675-678. https://doi.org/10.1136/gut.35.5.675
  19. Rigas, B., Goldman, I. S. and Levine, L. (1993). Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122, 518-523.
  20. Sexton, E., van Themsche, C., Leblanc, K., Parent, S., Lemoine, P. and Asselin, E. (2006). Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells. Mol. Cancer 5, 45. https://doi.org/10.1186/1476-4598-5-45
  21. Shao, J., Jung, C., Liu, C. and Sheng, H. (2005). Prostaglandin $E_2$ stimulates the $\beta$-catenin/T cell factor-dependent transcription in colon cancer. J. Biol. Chem. 280, 26565-26572. https://doi.org/10.1074/jbc.M413056200
  22. Shao, J., Lee, S. B., Guo, H., Evers, B. M. and Sheng, H. (2003). Prostaglandin $E_2$ stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res. 63, 5218-5223.
  23. Sheng, H., Shao, J., Washington, M. K. and DuBois, R. N. (2001). Prostaglandin $E_2$ increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276, 18075-18081. https://doi.org/10.1074/jbc.M009689200
  24. Sugimoto, Y. and Narumiya, S. (2007). Prostaglandin E receptors. J. Biol. Chem. 282, 11613-11617. https://doi.org/10.1074/jbc.R600038200
  25. Torok, N. J., Higuchi, H., Bronk, S. and Gores, G. J. (2002). Nitric oxide inhibits apoptosis downstream of cytochrome C release by nitosylating caspase-9. Cancer Res. 62, 1648- 1653.
  26. Ulrich, C. M., Bigler, J. and Potter, J. D. (2006). Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils, and pharmacogenetics. Nat. Rev. Cancer 6, 130-140. https://doi.org/10.1038/nrc1801
  27. Wang, D., Buchanan, F. G., Wang, H., Dey, S. K. and DuBois, R. N. (2005). Prostaglandin $E_2$ enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade. Cancer Res. 65, 1822-1829. https://doi.org/10.1158/0008-5472.CAN-04-3671
  28. Wiseman, H. and Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. J. Biol. Chem. 313, 17-29.
  29. Wolter, F., Akoglu, B., Clausnitzer, A. and Stein, J. (2001). Down-regulation of the cyclin D1/cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J. Nutr. 131, 2197-2203. https://doi.org/10.1093/jn/131.8.2197

Cited by

  1. Inhibitory Effects of Resveratrol on Melanin Synthesis in Ultraviolet B-Induced Pigmentation in Guinea Pig Skin vol.22, pp.1, 2014, https://doi.org/10.4062/biomolther.2013.081
  2. Comparison of the grain composition in resveratrol-enriched and glufosinate-tolerant rice ( Oryza sativa ) to conventional rice using univariate and multivariate analysis vol.52, 2016, https://doi.org/10.1016/j.jfca.2016.08.005
  3. Growth-Inhibiting Activity of Resveratrol Imine Analogs on Tumor Cells In Vitro vol.12, pp.1, 2017, https://doi.org/10.1371/journal.pone.0170502
  4. Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity vol.21, pp.4, 2013, https://doi.org/10.1016/j.bmc.2012.11.039
  5. Therapeutic Effects of Polyphenols on the Treatment of Colorectal Cancer by Regulating Wnt β-Catenin Signaling Pathway vol.2021, pp.None, 2010, https://doi.org/10.1155/2021/3619510